NasdaqCM - Nasdaq Real Time Price USD
Jade Biosciences, Inc. (JBIO)
8.61
+0.03
+(0.35%)
At close: May 13 at 4:00:02 PM EDT
9.04
+0.43
+(4.99%)
After hours: May 13 at 4:29:35 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DAKE BENJAMIN T President | Conversion of Exercise of derivative security | Aug 1, 2024 | 14,252 |
| ELDRIDGE GEORGE ARTHUR Chief Financial Officer | Sale | Jun 14, 2024 | 5,022 |
| GILLIES HUNTER C Officer | Sale | Jun 13, 2024 | 5,602 |
| GRAYZEL DAVID S Director | Sale | Apr 9, 2024 | -- |
| NIVEN RALPH W Officer | Sale | Feb 5, 2024 | 1,609 |
| NOYES TIMOTHY P. Chief Executive Officer | Sale | May 16, 2024 | 0 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 17, 2024 | -- |
| VERWIJS MARINUS Chief Technology Officer | Sale | Jun 14, 2024 | 0 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
14.75
-1.21%
VRDN Viridian Therapeutics, Inc.
12.81
-2.36%
GLUE Monte Rosa Therapeutics, Inc.
4.0400
-5.39%
PRAX Praxis Precision Medicines, Inc.
37.32
-2.86%
IKT Inhibikase Therapeutics, Inc.
2.2300
+1.83%
ATHA Athira Pharma, Inc.
0.2800
+3.70%
HLVX HilleVax, Inc.
1.9200
+1.59%
VOR Vor Biopharma Inc.
0.1600
-7.25%
IKNA Ikena Oncology, Inc.
1.1600
+1.75%
ATXS Astria Therapeutics, Inc.
3.9000
-10.76%